Fundz

Shennon Biotechnologies

SAN FRANCISCO, California, United States · Biotechnology

ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoim

Key facts

Headquarters
SAN FRANCISCO, California, United States
Employees
17
Industries
Biotechnology
Status
Private
Website
www.shennonbio.com
LinkedIn
Company page

Recent activity at Shennon Biotechnologies

Shennon Biotechnologies funding history

DateRoundAmount
Sep 2026Venture$12.0M
Mar 2023Venture$7.3M

Leadership

  • Li, Founder/CEO
  • Cyril Konto, M.D., Chief Executive Officer
  • JAMES HARDIMAN, Director
  • LI SUN, Executive Officer

Verified email and direct lines for Shennon Biotechnologies’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Employee benefit plans

Shennon Biotechnologies files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Shennon Biotechnologies in the news

Companies similar to Shennon Biotechnologies

About Shennon Biotechnologies: questions and answers

What does Shennon Biotechnologies do?

ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoim

Where is Shennon Biotechnologies headquartered?

Shennon Biotechnologies is headquartered in SAN FRANCISCO, California, United States.

How many employees does Shennon Biotechnologies have?

Shennon Biotechnologies has about 17 employees.

Has Shennon Biotechnologies raised funding?

Yes. Fundz has recorded 2 funding events for Shennon Biotechnologies. The most recent, $12.0M, was in Sep 2026.

Who leads Shennon Biotechnologies?

Li is a Founder/CEO at Shennon Biotechnologies.

What is the latest news on Shennon Biotechnologies?

On Sep 14, 2026, Shennon Biotechnologies Appoints Cyril Konto as Chief Executive Officer

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Shennon Biotechnologies across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.